Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,278 | -8,978 | -3,126 | -19,142 | -9,439 |
| Depreciation Amortization | -48 | -481 | -387 | -309 | -182 |
| Accounts payable and accrued liabilities | 814 | -152 | -9 | -159 | 122 |
| Other Working Capital | -265 | -4,192 | -4,685 | -3,500 | -3,050 |
| Other Operating Activity | -201 | -16,010 | -16,927 | 4,526 | 2,344 |
| Operating Cash Flow | $-7,978 | $-29,813 | $-25,134 | $-18,584 | $-10,205 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | 0 | -19,197 | -12,122 | -11,384 | -6,919 |
| Sale Of Investment | 17,900 | 46,465 | 35,465 | 25,500 | 18,000 |
| Other Investing Activity | 0 | 20,000 | 20,000 | 0 | 0 |
| Investing Cash Flow | $17,900 | $47,268 | $43,343 | $14,116 | $11,081 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3 | 16 | 10 | 10 | 0 |
| Financing Cash Flow | $3 | $16 | $10 | $10 | $0 |
| Beginning Cash Position | 31,374 | 13,903 | 13,903 | 13,903 | 13,903 |
| End Cash Position | 41,299 | 31,374 | 32,122 | 9,445 | 14,779 |
| Net Cash Flow | $9,925 | $17,471 | $18,219 | $-4,458 | $876 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,978 | -29,813 | -25,134 | -18,584 | -10,205 |
| Free Cash Flow | -7,978 | -29,813 | -25,134 | -18,584 | -10,205 |